| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/07391102.2020.1719203 |
| P698 | PubMed publication ID | 31965914 |
| P50 | author | Natalia Sizochenko | Q39924014 |
| Eugene Voronkov | Q88984995 | ||
| Karina Kapusta | Q92834236 | ||
| P2093 | author name string | Jerzy Leszczynski | |
| Wojciech Kolodziejczyk | |||
| Julia Saloni | |||
| Glake A Hill | |||
| Micah L Anderson | |||
| P2860 | cites work | HIV-1 integrase inhibitor resistance and its clinical implications | Q24628743 |
| Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137) | Q24656978 | ||
| PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints | Q27065420 | ||
| Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication | Q27661671 | ||
| Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage | Q27680666 | ||
| Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells | Q28536951 | ||
| A semiempirical free energy force field with charge-based desolvation | Q29614316 | ||
| A hierarchical approach to all-atom protein loop prediction | Q29615859 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening | Q29617343 | ||
| Discovery of N-aryl-naphthylamines as in vitro inhibitors of the interaction between HIV integrase and the cofactor LEDGF/p75. | Q35684884 | ||
| Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go. | Q37014096 | ||
| LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV | Q37035177 | ||
| Targeting HIV: past, present and future | Q37853207 | ||
| Dolutegravir for the treatment of HIV. | Q37989555 | ||
| LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 - 2014). | Q38199193 | ||
| HIV-1 integrase multimerization as a therapeutic target | Q38380688 | ||
| Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization | Q39337204 | ||
| LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions | Q41454699 | ||
| Insight into the binding mode between N-methyl pyrimidones and prototype foamy virus integrase-DNA complex by QM-polarized ligand docking and molecular dynamics simulations | Q41595035 | ||
| Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments | Q44012277 | ||
| Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection | Q46396658 | ||
| The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin | Q47682341 | ||
| Design, synthesis, and structure-activity relationship of N-arylnaphthylamine derivatives as amyloid aggregation inhibitors. | Q48381509 | ||
| QSPR modeling of optical rotation of amino acids using specific quantum chemical descriptors. | Q49891584 | ||
| Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function | Q56885198 | ||
| Designed antiviral ankyrin – A computational approach to combat HIV-1 via intracellular pathway by targeting the viral capsid of HIV-1 | Q60218050 | ||
| How to judge whether QSAR/read-across predictions can be trusted: a novel approach for establishing a model's applicability domain | Q63284221 | ||
| Current Computational Approaches for the Development of Anti-HIV Inhibitors: An Overview | Q90188201 | ||
| Quantitative Structure - Activity Relationship Study for HIV-1 LEDGF/p75 inhibitors | Q90188279 | ||
| Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV | Q91606964 | ||
| P304 | page(s) | 1-14 | |
| P577 | publication date | 2020-01-31 | |
| P1433 | published in | Journal of Biomolecular Structure and Dynamics | Q15754747 |
| P1476 | title | N-arylnaphthylamines as inhibitors of human immunodeficiency virus integrase - lens epithelium-derived growth factor interactions: theoretical studies |
Search more.